HI
CELG

Hudock Inc’s Celgene Corp CELG Stock Holding History

Hudock Inc’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100
Closed -$9K – 764
2019
Q3 		$9K Hold
100
– – ﹤0.01% 435
2019
Q2 		$9K Hold
100
– – ﹤0.01% 433
2019
Q1 		$9K Sell
100
-125
-56% -$10.9K ﹤0.01% 428
2018
Q4 		$14K Hold
225
– – 0.01% 361
2018
Q3 		$20K Hold
225
– – 0.01% 352
2018
Q2 		$17K Buy
225
+45
+25% +$3.74K 0.01% 366
2018
Q1 		$16K Buy
180
+13
+8% +$1.25K 0.01% 391
2017
Q4 		$17K Buy
167
+65
+64% +$7.33K 0.01% 374
2017
Q3 		$14K Hold
102
– – 0.01% 393
2017
Q2 		$13K Buy
102
+2
+2% +$245 0.01% 383
2017
Q1 		$12K Hold
100
– – 0.01% 381
2016
Q4 		$11K Hold
100
– – 0.01% 382
2016
Q3 		$10K Hold
100
– – 0.01% 403
2016
Q2 		$9K Hold
100
– – ﹤0.01% 420
2016
Q1 		$10K Hold
100
– – 0.01% 409
2015
Q4 		$11K Hold
100
– – ﹤0.01% 381
2015
Q3 		$10K Hold
100
– – ﹤0.01% 415
2015
Q2 		$11K Hold
100
– – 0.01% 400
2015
Q1 		$12K Hold
100
– – 0.01% 414
2014
Q4 		$11K Buy
+100
New +$10.5K 0.01% 378

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Hudock Inc's CELG Position: Q4 2019 in Review

Hudock Inc sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100 shares — an estimated $9K sold.

Hudock Inc first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $20K in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hudock Inc reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hudock Inc sold 100 Celgene Corp shares in Q4 2019, an estimated $9K.
  • Hudock Inc first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • Hudock Inc's Celgene Corp position peaked at $20K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hudock Inc's 13F filing for Q4 2019, filed 21 Jan 2020.